Teva Pharmaceuticals, and MedinCell announced that the New Drug Application for TV-46000/mdc-IRM for the treatment of schizophrenia has been accepted by the US FDA
[Teva Pharmaceuticals, Ltd. (BusinessWire, Inc.)]
Sorry, but the selected Zotpress account can't be found.
